Precious Lim

993 total citations
10 papers, 787 citations indexed

About

Precious Lim is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Precious Lim has authored 10 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Hepatology and 6 papers in Epidemiology. Recurrent topics in Precious Lim's work include Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (5 papers) and Signaling Pathways in Disease (4 papers). Precious Lim is often cited by papers focused on Hepatitis C virus research (7 papers), Hepatitis B Virus Studies (5 papers) and Signaling Pathways in Disease (4 papers). Precious Lim collaborates with scholars based in United States, Switzerland and Germany. Precious Lim's co-authors include Hongmin Wang, Mervyn J. Monteiro, Philippe Gallay, Mariusz Karbowski, Udayan Chatterji, Michael Bobardt, Grégoire Vuagniaux, Bruce E. Vogel, Matthias Rieckher and Craig E. Cameron and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and PLoS ONE.

In The Last Decade

Precious Lim

10 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Precious Lim United States 9 499 289 272 161 93 10 787
Fumiko Shinkai‐Ouchi Japan 13 414 0.8× 88 0.3× 107 0.4× 59 0.4× 8 0.1× 22 627
Jean-Daniel Abraham France 13 184 0.4× 147 0.5× 129 0.5× 39 0.2× 14 0.2× 20 503
Theresa Heinrich Germany 7 318 0.6× 129 0.4× 533 2.0× 52 0.3× 24 0.3× 10 939
Yong‐Yea Park South Korea 12 674 1.4× 27 0.1× 201 0.7× 32 0.2× 21 0.2× 13 876
Ursula Bodendorf Switzerland 11 336 0.7× 34 0.1× 46 0.2× 42 0.3× 18 0.2× 17 595
Sylvie Prigent France 13 469 0.9× 140 0.5× 210 0.8× 38 0.2× 2 0.0× 17 756
Kelly A. Kaihara United States 13 381 0.8× 82 0.3× 89 0.3× 46 0.3× 3 0.0× 16 652
Young‐Gun Yoo South Korea 10 412 0.8× 80 0.3× 177 0.7× 62 0.4× 7 0.1× 11 726
Zhiwei Sun China 14 210 0.4× 19 0.1× 76 0.3× 37 0.2× 56 0.6× 30 481
Bryan Downie United States 9 336 0.7× 48 0.2× 67 0.2× 57 0.4× 11 0.1× 26 537

Countries citing papers authored by Precious Lim

Since Specialization
Citations

This map shows the geographic impact of Precious Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Precious Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Precious Lim more than expected).

Fields of papers citing papers by Precious Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Precious Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Precious Lim. The network helps show where Precious Lim may publish in the future.

Co-authorship network of co-authors of Precious Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Precious Lim. A scholar is included among the top collaborators of Precious Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Precious Lim. Precious Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bobardt, Michael, Udayan Chatterji, Precious Lim, Katarzyna Gawlik, & Philippe Gallay. (2014). Both Cyclophilin Inhibitors and Direct-Acting Antivirals Prevent PKR Activation in HCV-Infected Cells. PubMed. 8(1). 1–8. 6 indexed citations
2.
Lim, Precious & Philippe Gallay. (2014). Hepatitis C NS5A protein: two drug targets within the same protein with different mechanisms of resistance. Current Opinion in Virology. 8. 30–37. 21 indexed citations
3.
Gawlik, Katarzyna, et al.. (2014). HCV Core Residues Critical for Infectivity Are Also Involved in Core-NS5A Complex Formation. PLoS ONE. 9(2). e88866–e88866. 22 indexed citations
4.
Hopkins, Sam, Michael Bobardt, Udayan Chatterji, et al.. (2012). The Cyclophilin Inhibitor SCY-635 Disrupts Hepatitis C Virus NS5A-Cyclophilin A Complexes. Antimicrobial Agents and Chemotherapy. 56(7). 3888–3897. 48 indexed citations
5.
Lim, Precious, Udayan Chatterji, Suresh D. Sharma, et al.. (2012). Correlation between NS5A Dimerization and Hepatitis C Virus Replication. Journal of Biological Chemistry. 287(36). 30861–30873. 53 indexed citations
6.
Coelmont, Lotte, Xavier Hanoulle, Udayan Chatterji, et al.. (2010). DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A. PLoS ONE. 5(10). e13687–e13687. 143 indexed citations
7.
Chatterji, Udayan, Precious Lim, Michael Bobardt, et al.. (2010). HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A–cyclophilin A interaction to cyclophilin inhibitors. Journal of Hepatology. 53(1). 50–56. 96 indexed citations
8.
Lim, Precious, Rebecca Danner, Jing Liang, et al.. (2009). Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD. The Journal of Cell Biology. 187(2). 201–217. 118 indexed citations
9.
Wang, Hongmin, Precious Lim, Mariusz Karbowski, & Mervyn J. Monteiro. (2008). Effects of overexpression of Huntingtin proteins on mitochondrial integrity. Human Molecular Genetics. 18(4). 737–752. 183 indexed citations
10.
Wang, Hongmin, et al.. (2006). Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin. Human Molecular Genetics. 15(6). 1025–1041. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fumiko Shinkai‐Ouchi Breakdown of academic impact, for papers by Jean-Daniel Abraham Breakdown of academic impact, for papers by Theresa Heinrich Breakdown of academic impact, for papers by Yong‐Yea Park Breakdown of academic impact, for papers by Ursula Bodendorf Breakdown of academic impact, for papers by Sylvie Prigent Breakdown of academic impact, for papers by Kelly A. Kaihara Breakdown of academic impact, for papers by Young‐Gun Yoo Breakdown of academic impact, for papers by Zhiwei Sun Breakdown of academic impact, for papers by Bryan Downie
Rankless by CCL
2026